<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26666374</article-id><article-id pub-id-type="pmc">4678643</article-id><article-id pub-id-type="publisher-id">1093</article-id><article-id pub-id-type="doi">10.1186/s13063-015-1093-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Evaluation of acute effect of light-emitting diode (LED) phototherapy on muscle deoxygenation and pulmonary oxygen uptake kinetics in patients with diabetes mellitus: study protocol for a randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Francisco</surname><given-names>Cristina de Oliveira</given-names></name><address><email>cristinaft05@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Beltrame</surname><given-names>Thomas</given-names></name><address><email>beltramethomas@gmail.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Ferraresi</surname><given-names>Cleber</given-names></name><address><email>cleber.ferraresi@gmail.com</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Parizotto</surname><given-names>Nivaldo Antonio</given-names></name><address><email>nivaldoaparizotto@hotmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Bagnato</surname><given-names>Vanderlei Salvador</given-names></name><address><email>vander@ifsc.usp.br</email></address><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Borghi Silva</surname><given-names>Audrey</given-names></name><address><email>audrey@ufscar.br</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Benze</surname><given-names>Benedito Galv&#x000e3;o</given-names></name><address><email>benze@ufscar.br</email></address><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Porta</surname><given-names>Alberto</given-names></name><address><email>alberto.porta@unimi.it</email></address><xref ref-type="aff" rid="Aff6"/><xref ref-type="aff" rid="Aff7"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Catai</surname><given-names>Aparecida Maria</given-names></name><address><email>mcatai@ufscar.br</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Department of Physiotherapy, Federal University of S&#x000e3;o Carlos, Rod. Washington Lu&#x000ed;s, km 235, 13.565-905 S&#x000e3;o Carlos, S&#x000e3;o Paulo Brazil </aff><aff id="Aff2"><label/>Faculty of Applied Health Sciences, University of Waterloo, 200 University Ave W, N2L 3G1 Waterloo, Ontario Canada </aff><aff id="Aff3"><label/>Wellman Center for Photomedicine, Massachusetts General Hospital - Harvard Medical School, 55 Fruit Street, MA 02114 Boston, Massachusetts USA </aff><aff id="Aff4"><label/>S&#x000e3;o Carlos Institute of Physics, University od S&#x000e3;o Paulo, Av. Trabalhador S&#x000e3;o-carlense, 400, 13566-590 S&#x000e3;o Carlos, S&#x000e3;o Paulo Brazil </aff><aff id="Aff5"><label/>Department of Statistics, Federal University of S&#x000e3;o Carlos, Rod. Washington Lu&#x000ed;s, km 235, 13.565-905 S&#x000e3;o Carlos, S&#x000e3;o Paulo Brazil </aff><aff id="Aff6"><label/>Department of Biomedical Sciences for Health, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy </aff><aff id="Aff7"><label/>Department of Cardiothoracic, Vascular Anesthesia and Intensive Care, IRCCS, Policlinico San Donato, Milan, Italy </aff></contrib-group><pub-date pub-type="epub"><day>15</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>16</volume><elocation-id>572</elocation-id><history><date date-type="received"><day>6</day><month>8</month><year>2015</year></date><date date-type="accepted"><day>30</day><month>11</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Francisco et al. 2015</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Type 2 diabetes mellitus (DM) is responsible for a significant reduction in the quality of life due to its negative impact on functional capacity. Cardiopulmonary fitness impairment in DM patients has been associated with limited tissue oxygenation. Phototherapy is widely utilized to treat several disorders due to expected light-tissue interaction. This type of therapy may help to improve muscular oxygenation, thereby increasing aerobic fitness and functional capacity.</p></sec><sec><title>Methods/Design</title><p>This study is a randomized, double-blind, placebo-controlled crossover trial approved by the Ethics Committee of the Federal University of S&#x000e3;o Carlos and registered at ClinicalTrials.gov. Four separate tests will be performed to evaluate the acute effect of phototherapy. All participants will receive both interventions in random order: light-emitting diode therapy (LEDT) and placebo, with a minimum 14-day interval between sessions (washout period). Immediately after the intervention, participants will perform moderate constant workload cycling exercise corresponding to 80&#x000a0;% of the pulmonary oxygen uptake <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left({\mathrm{p}\overset{\cdotp }{\mathrm{V}}\mathrm{O}}_2\right) $$\end{document}</tex-math><mml:math id="M2"><mml:mfenced close=")" open="("><mml:msub><mml:mrow><mml:mi mathvariant="normal">p</mml:mi><mml:mover accent="true"><mml:mi mathvariant="normal">V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:mi mathvariant="normal">O</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mfenced></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq1.gif"/></alternatives></inline-formula> during the gas exchange threshold (GET). LEDT will be administered with a multidiode cluster probe (50 GaAIA LEDs, 850 &#x003b7;m, 75&#x000a0;mW each diode, and 3&#x000a0;J per point) before each exercise session. Pulmonary oxygen uptake, muscle oxygenation, heart rate, and arterial pressure will be measured using a computerized metabolic cart, a near-infrared spectrometer, an electrocardiogram, and a photoplethysmography system, respectively.</p></sec><sec><title>Discussion</title><p>The main objective of this study is to evaluate the acute effects of muscular pre-conditioning using LED phototherapy on pulmonary oxygen uptake, muscle oxygenation, heart rate, and arterial pressure dynamics during dynamic moderate exercise. We hypothesize that phototherapy may be beneficial to optimize aerobic fitness in the DM population. Data will be published after the study is completed.</p></sec><sec><title>Trial registration</title><p>Registered at ClinicalTrials.gov under trial number <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01889784?term=NCT01889784&#x00026;rank=1">NCT01889784</ext-link> (date of registration 5 June 2013).</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Type 2 diabetes mellitus</kwd><kwd>phototherapy</kwd><kwd>light-emitting diode</kwd><kwd>oxygen uptake</kwd><kwd>physical exercise</kwd><kwd>oxygen uptake kinetics</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001807</institution-id><institution>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (BR)</institution></institution-wrap></funding-source><award-id>2013/08183-7</award-id><principal-award-recipient><name><surname>Francisco</surname><given-names>Cristina de Oliveira</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001807</institution-id><institution>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (BR)</institution></institution-wrap></funding-source><award-id>2013/07953-3</award-id><principal-award-recipient><name><surname>Catai</surname><given-names>Aparecida Maria</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Type 2 diabetes (DM) is a significant health problem worldwide due to its high prevalence and mortality [<xref ref-type="bibr" rid="CR1">1</xref>]. It is characterized by hyperglycemia caused by defects in insulin secretion and/or insulin action. DM is associated with many well-known chronic comorbidities and complications that compromise many tissues, especially the blood vessels, heart, and nerves [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p>Individuals with DM have reduced aerobic fitness characterized by lower peak pulmonary oxygen uptake <inline-formula id="IEq3"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left(p\overset{\cdotp }{V}{O}_2\right) $$\end{document}</tex-math><mml:math id="M4"><mml:mfenced close=")" open="("><mml:mrow><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq3.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. In addition, <inline-formula id="IEq4"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M6"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq4.gif"/></alternatives></inline-formula> kinetics analysis has been used to characterize <inline-formula id="IEq5"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M8"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq5.gif"/></alternatives></inline-formula> dynamics during submaximal exercise transitions [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. The <inline-formula id="IEq6"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M10"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq6.gif"/></alternatives></inline-formula> kinetics during exercise transitions are related to the cardiorespiratory system&#x02019;s ability to offer O<sub>2</sub> and the capacity of the exercising muscle to utilize this O<sub>2</sub> [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. DM patients have delayed <inline-formula id="IEq7"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M12"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq7.gif"/></alternatives></inline-formula> response after the onset of light to moderate exercise [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] and premature muscular fatigue [<xref ref-type="bibr" rid="CR9">9</xref>] in comparison with a control group. Many potential mechanisms could explain these impaired responses, for example, reduced muscle blood flow [<xref ref-type="bibr" rid="CR10">10</xref>] and capillary density [<xref ref-type="bibr" rid="CR11">11</xref>], defects in muscular oxygen diffusion, and lower mitochondrial oxygen utilization [<xref ref-type="bibr" rid="CR5">5</xref>] and function [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p>Phototherapy is a widely used resource due to its effect on biological tissues, potentially improving muscular efficiency and aerobic fitness [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. Studies with animals have shown enhanced mitochondrial function [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], microcirculation, and tissue oxygenation [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>] mediated by phototherapy. Additionally, studies with healthy humans demonstrate improvements in muscular function, fatigue resistance, <inline-formula id="IEq8"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M14"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq8.gif"/></alternatives></inline-formula>, and exercise tolerance [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] and decreased concentrations of lactate and muscle damage markers [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>].</p><p>DM patients have an impaired ability to deliver oxygen (O<sub>2</sub>) to the muscle and possibly to use this O<sub>2</sub> during exercise, which leads to an imbalance between muscle blood flow and <inline-formula id="IEq9"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M16"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq9.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR27">27</xref>], resulting in hampered <inline-formula id="IEq10"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M18"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq10.gif"/></alternatives></inline-formula> dynamics. Therefore, the main aim of this study is to evaluate the acute effects of LED phototherapy on muscle oxygenation and <inline-formula id="IEq11"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M20"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq11.gif"/></alternatives></inline-formula> kinetics in individuals with DM during moderate cycling exercise. We hypothesize that phototherapy will promote therapeutic effects such as improved aerobic fitness, which could ultimately lead to better functional capacity.</p></sec><sec id="Sec2"><title>Methods/Design</title><sec id="Sec3"><title>Design</title><p>This study is a randomized, double-blind, placebo-controlled crossover trial approved by the Ethics Committee of Federal University of S&#x000e3;o Carlos (number 13573013.1.0000.5504) and registered at ClinicalTrials.gov under Trial Number NCT01889784. This study will be conducted in accordance with the human research standards set out by the National Health Council Resolution 196/96. The subjects will be included in the study after providing written informed consent.</p><p>The subjects will be divided into two groups: DM group (DMG) and healthy group (HG). After screening, the subjects of both groups who meet the eligibility criteria will be randomly allocated to one of two subgroups (A and B) as described in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>. Four separate tests will be conducted to evaluate the acute effect of phototherapy. All subjects will receive both interventions, light-emitting diode therapy (LEDT) and placebo, with a minimum 14-day interval between sessions (washout period). The subgroups will determine the intervention order because the interventions will be alternated in each visit (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>). The subjects in subgroup A will receive LEDT in the first and third sessions and placebo in the second and fourth sessions. Subjects in subgroup B will receive the reverse order. The researcher responsible for the randomization process will also prepare the LEDT device (effective or placebo) before each visit and will not analyze the data.<fig id="Fig1"><label>Fig. 1</label><caption><p>Study design flowchart. Screening and group/subgroup allocation are described in <bold>a</bold>. The intervention order of the study is described in <bold>b</bold>. DMG, diabetes mellitus group; HG, healthy group</p></caption><graphic xlink:href="13063_2015_1093_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec4"><title>Subjects</title><p>All subjects must be free of overt coronary disease, and they must be between 40 and 64&#x000a0;years of age. DM individuals must have a diagnosis according to the recommendations of the American Diabetes Association [<xref ref-type="bibr" rid="CR2">2</xref>]. The groups will be matched by age and body mass index (BMI). To achieve that, we will first screen and test the DMG, then evaluate the control group matching age and BMI.</p><p>Exclusion criteria are BMI&#x02009;&#x0003e;&#x02009;35&#x000a0;kg/m<sup>2</sup>, high-sensitivity C-reactive protein (hs-CRP)&#x02009;&#x0003e;&#x02009;3.0&#x000a0;mg/L, smoking, anemia, alcoholism, use of anti-inflammatory or inhalable drugs, known respiratory and inflammatory diseases, congestive heart failure, and disability conditions that preclude exercise. Healthy subjects will be excluded if they have direct family members with DM.</p></sec><sec id="Sec5"><title>Sample characterization</title><p>Glycohemoglobin (HbA<sub>1c),</sub> fasting plasma insulin level, fasting plasma glucose, plasma concentration of CRP, and lipid profile will be measured after 10 to 12&#x000a0;hours of fasting using the analyzer ADVIA 1800 Chemistry System (Siemens, Tarrytown, NY, USA). The degree of insulin resistance will be determined at baseline by the homeostasis model assessment of insulin resistance (HOMA-IR), according to the formula: HOMA-IR&#x02009;=&#x02009;fasting plasma insulin (&#x003bc;U/ml) x fasting plasma glucose (mmol/L)/22.5 [<xref ref-type="bibr" rid="CR28">28</xref>]. Body composition will be evaluated by tetrapolar bioelectrical impedance analysis (model BC-558, Tanita Corporation of America Inc., Arlington Heights, IL, USA) which calculates body fat, total body water, muscle mass, visceral fat, and bone mass. The subjects will be required to avoid eating and drinking for 4&#x000a0;hours and to urinate prior to the assessment.</p></sec><sec id="Sec6"><title>Protocol</title><p>Following the screening session, the subjects will return to the laboratory on 5 different days (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). They will be asked to avoid alcohol and caffeine and refrain from exercise for 24&#x000a0;hours before testing. All tests will take place in the morning, at the same time of the day.<fig id="Fig2"><label>Fig. 2</label><caption><p>Experimental protocol flowchart. LEDT, light-emitting diode therapy</p></caption><graphic xlink:href="13063_2015_1093_Fig2_HTML" id="MO2"/></fig></p><p>On the first day, incremental exercise on a cycloergometer (Quinton Corival 400, Seattle, WA, USA) will be performed to determine the gas exchange threshold (GET) and peak <inline-formula id="IEq12"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M22"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq12.gif"/></alternatives></inline-formula>. Subjects should maintain a cycling cadence of approximately 60&#x000a0;rpm. The workload increment will be determined for each subject in accordance with Wasserman et al. [<xref ref-type="bibr" rid="CR29">29</xref>]. The GET will be determined by three independent observers according to the ventilatory method [<xref ref-type="bibr" rid="CR29">29</xref>]. The peak <inline-formula id="IEq13"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M24"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq13.gif"/></alternatives></inline-formula> will be the mean <inline-formula id="IEq14"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M26"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq14.gif"/></alternatives></inline-formula> value of the last 30&#x000a0;seconds during the incremental exercise. It will be assumed that peak <inline-formula id="IEq15"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M28"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq15.gif"/></alternatives></inline-formula> has been achieved when the respiratory exchange ratio (RER) at exercise peak reaches a value higher than 1.1 [<xref ref-type="bibr" rid="CR30">30</xref>].</p><p>After that, the subjects will return to the laboratory four more times to receive the muscular pre-conditioning intervention (LEDT or placebo) according to the randomization. Immediately after the intervention, the subjects will perform moderate constant workload cycling exercise corresponding to 80&#x000a0;% of the <inline-formula id="IEq16"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M30"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq16.gif"/></alternatives></inline-formula> during the GET. The LEDT will be administered with a multidiode cluster probe (50 GaAIA LEDs, 850 &#x003b7;m, 75&#x000a0;mW each diode, and 3&#x000a0;J per point) before each exercise session. The probe will be in direct contact with skin bilaterally for 40&#x000a0;seconds, delivering 150&#x000a0;J of total energy to each quadriceps and triceps surae muscle. Placebo will follow the same procedure, but, the LEDT device will be turned off.</p><p>The constant workload exercise protocol will be preceded by a resting period and 3&#x000a0;minutes of freewheel pedaling. Afterwards, 6&#x000a0;minutes of exercise at target workload will be performed followed by a 6-minute cool-down period of freewheel pedaling.</p></sec><sec id="Sec7"><title>Measurements</title><p>The <inline-formula id="IEq17"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M32"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq17.gif"/></alternatives></inline-formula>, carbon dioxide output (<italic>pVCO</italic><sub>2</sub>), minute ventilation (VE), and respiratory exchange rate (RER) will be measured breath-by-breath using a computerized metabolic cart (Vmax29c, Sensor Medics, Yorba Linda, CA, USA) previously calibrated for each session.</p><p>Electrocardiography (ECG) will be continuously recorded (CM5 lead) with a bioamplifier (BioAmp Power Lab, ADInstruments, Castle Hill, NSW, Australia) and a data acquisition system (Power Lab, ADInstruments, Castle Hill, NSW, Australia). Heart rate (HR) will be estimated based on the ECG signal. Finger arterial pressure will be measured using a photoplethysmography system (Finometer Pro, Finapres Medical System, Amsterdam, Netherlands). The finger cuff will be placed on the middle finger of the left hand. To correct the hydrostatic pressure changes related to the heart, a height correction will be used as recommended by the manufacturer [<xref ref-type="bibr" rid="CR31">31</xref>].</p><p>Local tissue oxygenation of the vastus lateralis and gastrocnemius medialis of the right leg will be measured using near-infrared spectroscopy (NIRS) (Oxymon, Artinis Medical Systems, Nijmegen, Netherlands). NIRS provides measurements of changes in concentrations of deoxygenated and oxygenated hemoglobin (HHb and O<sub>2</sub>Hb, respectively). In addition, the tissue saturation index (TSI) will be measured. To avoid any motion artifact and ambient light influences, the probe will be fixed by tape and then a dark cloth will be gently wrapped around the thigh and calf region.</p><p>Before and after the constant workload exercise protocol, blood samples will be collected via earlobe puncture in order to verify lactate and glucose using an automated glucose analyzer (YSI 2300 STAT PLUS &#x02013; Yellow Springs Instruments, Yellow Springs, OH, USA) that has been previously calibrated according to the manufacturer's instructions.</p></sec><sec id="Sec8"><title>Data analysis procedures</title><p>The <inline-formula id="IEq18"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M34"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq18.gif"/></alternatives></inline-formula> and NIRS data collected during constant workload exercise will be submitted to time domain kinetics analysis as previously described [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR32">32</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>]. The data obtained in the two repetitions of the same constant workload protocol for each intervention (LEDT or placebo) will be time-aligned and second-by-second interpolated; then, the point-by-point mean between tests will be finally submitted to kinetics analysis.</p></sec><sec id="Sec9"><title>Statistical analysis</title><p>The data will be expressed as mean and standard deviation values. The Kolmogorov-Smirnov and Levene tests will be used to test the data for Gaussian distribution and variance, respectively. The statistics analysis will be performed using two-way repeated-measures ANOVA and a post hoc Tukey test for intergroup, intragroup, and multiple comparisons. The level of significance will be set at 5&#x000a0;% (p&#x02009;&#x0003c;&#x02009;0.05). The statistical power will be set at 0.80, which is the minimal value recommended in the literature to minimize type II error.</p></sec></sec><sec id="Sec10"><title>Discussion</title><p>The chronic effect of phototherapy has been widely studied and shows promising results related to increased peak <inline-formula id="IEq19"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M36"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq19.gif"/></alternatives></inline-formula>, reduction in fatigue, and lactate and C-reactive protein concentrations [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>]. This novel therapeutic tool is generally studied in healthy participants [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]; however, the acute effects of phototherapy are still unknown in DM and its impact on <inline-formula id="IEq20"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M38"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq20.gif"/></alternatives></inline-formula> dynamics still needs further clarification.</p><p>The effects of LEDT could be beneficial to the DM population because the exercise intolerance of this population decreases quality of life and further increases cardiovascular risk. Therefore, the purpose of this randomized clinical trial is to evaluate the acute effects of LEDT on <inline-formula id="IEq21"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ p\overset{\cdotp }{V}{O}_2 $$\end{document}</tex-math><mml:math id="M40"><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq21.gif"/></alternatives></inline-formula> dynamics in subjects with DM and healthy age- and sex-matched subjects. The results will elucidate the effects of LEDT and may support the use of this therapy in individuals with DM.</p><p>Data will be published after the study is completed.</p><sec id="Sec11"><title>Trial status</title><p>Patient recruitment is currently underway.</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>BMI</term><def><p>body mass index</p></def></def-item><def-item><term>DM</term><def><p>Type 2 diabetes</p></def></def-item><def-item><term>DMG</term><def><p>Type 2 diabetes group</p></def></def-item><def-item><term>ECG</term><def><p>electrocardiogram</p></def></def-item><def-item><term>GET</term><def><p>gas exchange threshold</p></def></def-item><def-item><term>HbA<sub>1c</sub></term><def><p>glycohemoglobin</p></def></def-item><def-item><term>HHb</term><def><p>deoxygenated hemoglobin</p></def></def-item><def-item><term>HG</term><def><p>healthy group</p></def></def-item><def-item><term>(HOMA-IR)</term><def><p>homeostasis model assessment of insulin resistance</p></def></def-item><def-item><term>HR</term><def><p>heart rate</p></def></def-item><def-item><term>hs-CRP</term><def><p>high-sensitivity C-reactive protein</p></def></def-item><def-item><term>LED</term><def><p>light emitting diode</p></def></def-item><def-item><term>LEDT</term><def><p>light-emitting diode therapy</p></def></def-item><def-item><term>NIRS</term><def><p>near-infrared spectroscopy</p></def></def-item><def-item><term>O<sub>2</sub></term><def><p>oxygen</p></def></def-item><def-item><term>O<sub>2</sub>Hb</term><def><p>oxygenated hemoglobin</p></def></def-item><def-item><term>pVCO<sub>2</sub></term><def><p>carbon dioxide output</p></def></def-item><def-item><term><inline-formula id="IEq2"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \left(p\overset{\cdotp }{V}{O}_2\right) $$\end{document}</tex-math><mml:math id="M42"><mml:mfenced close=")" open="("><mml:mrow><mml:mi>p</mml:mi><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000b7;</mml:mo></mml:mover><mml:msub><mml:mi>O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="13063_2015_1093_Article_IEq2.gif"/></alternatives></inline-formula></term><def><p>pulmonary oxygen uptake</p></def></def-item><def-item><term>RER</term><def><p>respiratory exchange ratio</p></def></def-item><def-item><term>TSI</term><def><p>tissue saturation index</p></def></def-item><def-item><term>VE</term><def><p>minute ventilation</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>COF contributed to the conception and experimental design, data collection and analysis, manuscript writing, and final approval of the version to be published. TB contributed to the conception and experimental design, critical revision of the manuscript, analysis and interpretation of the data, and final approval of the version to be published. CF contributed to the conception and experimental design, final approval of the version to be published. NAP, VSB, ABS, AP, and BGB contributed to the experimental design, critical revision of the manuscript, and the final approval of the version to be published. AMC contributed to the conception and experimental design, data analysis and interpretation, manuscript revision/editing, and final approval of the version to be published.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This study has the financial support of S&#x000e3;o Paulo State Research Foundation - FAPESP (grant 2013/08183-7 to COF and 2013/07953-3 to AMC).</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>S</given-names></name><name><surname>Roglic</surname><given-names>G</given-names></name><name><surname>Green</surname><given-names>A</given-names></name><name><surname>Sicree</surname><given-names>R</given-names></name><name><surname>King</surname><given-names>H</given-names></name></person-group><article-title>Global prevalence of diabetes: estimates for the year, and projections for 2030</article-title><source>Diabetes Care</source><year>2004</year><volume>2000</volume><fpage>1047</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.2337/diacare.27.5.1047</pub-id><pub-id pub-id-type="pmid">15111519</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Expert Committee on the D</collab><collab>Classification of Diabetes M</collab></person-group><article-title>Report of the expert committee on the diagnosis and classification of diabetes mellitus</article-title><source>Diabetes Care</source><year>2003</year><volume>26</volume><issue>Suppl 1</issue><fpage>S5</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12502614</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyoum</surname><given-names>B</given-names></name><name><surname>Estacio</surname><given-names>RO</given-names></name><name><surname>Berhanu</surname><given-names>P</given-names></name><name><surname>Schrier</surname><given-names>RW</given-names></name></person-group><article-title>Exercise capacity is a predictor of cardiovascular events in patients with type 2 diabetes mellitus</article-title><source>Diab Vasc Dis Res</source><year>2006</year><volume>3</volume><fpage>197</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.3132/dvdr.2006.030</pub-id><pub-id pub-id-type="pmid">17160916</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadeau</surname><given-names>KJ</given-names></name><name><surname>Zeitler</surname><given-names>PS</given-names></name><name><surname>Bauer</surname><given-names>TA</given-names></name><name><surname>Brown</surname><given-names>MS</given-names></name><name><surname>Dorosz</surname><given-names>JL</given-names></name><name><surname>Draznin</surname><given-names>B</given-names></name><etal/></person-group><article-title>Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity</article-title><source>J Clin Endocrinol Metab</source><year>2009</year><volume>94</volume><fpage>3687</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1210/jc.2008-2844</pub-id><pub-id pub-id-type="pmid">19584191</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regensteiner</surname><given-names>JG</given-names></name><name><surname>Bauer</surname><given-names>TA</given-names></name><name><surname>Reusch</surname><given-names>JE</given-names></name><name><surname>Brandenburg</surname><given-names>SL</given-names></name><name><surname>Sippel</surname><given-names>JM</given-names></name><name><surname>Vogelsong</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Abnormal oxygen uptake kinetic responses in women with type II diabetes mellitus</article-title><source>J Appl Physiol</source><year>1998</year><volume>85</volume><fpage>310</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9655791</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francisco</surname><given-names>CO</given-names></name><name><surname>Catai</surname><given-names>AM</given-names></name><name><surname>Moura-Tonello</surname><given-names>SC</given-names></name><name><surname>Lopes</surname><given-names>SL</given-names></name><name><surname>Benze</surname><given-names>BG</given-names></name><name><surname>Del Vale</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Cardiorespiratory fitness, pulmonary function and C-reactive protein levels in nonsmoking individuals with diabetes</article-title><source>Braz J Med Biol Res</source><year>2014</year><volume>47</volume><fpage>426</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1590/1414-431X20143370</pub-id><pub-id pub-id-type="pmid">24760118</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughson</surname><given-names>RL</given-names></name></person-group><article-title>Oxygen uptake kinetics: historical perspective and future directions</article-title><source>Appl Physiol Nutr Metab</source><year>2009</year><volume>34</volume><fpage>840</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1139/H09-088</pub-id><pub-id pub-id-type="pmid">19935845</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regensteiner</surname><given-names>JG</given-names></name><name><surname>Sippel</surname><given-names>J</given-names></name><name><surname>McFarling</surname><given-names>ET</given-names></name><name><surname>Wolfel</surname><given-names>EE</given-names></name><name><surname>Hiatt</surname><given-names>WR</given-names></name></person-group><article-title>Effects of non-insulin-dependent diabetes on oxygen consumption during treadmill exercise</article-title><source>Med Sci Sports Exerc</source><year>1995</year><volume>27</volume><fpage>875</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1249/00005768-199505000-00007</pub-id><pub-id pub-id-type="pmid">7658949</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheuermann-Freestone</surname><given-names>M</given-names></name><name><surname>Madsen</surname><given-names>PL</given-names></name><name><surname>Manners</surname><given-names>D</given-names></name><name><surname>Blamire</surname><given-names>AM</given-names></name><name><surname>Buckingham</surname><given-names>RE</given-names></name><name><surname>Styles</surname><given-names>P</given-names></name><etal/></person-group><article-title>Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes</article-title><source>Circulation</source><year>2003</year><volume>107</volume><fpage>3040</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000072789.89096.10</pub-id><pub-id pub-id-type="pmid">12810608</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingwell</surname><given-names>BA</given-names></name><name><surname>Formosa</surname><given-names>M</given-names></name><name><surname>Muhlmann</surname><given-names>M</given-names></name><name><surname>Bradley</surname><given-names>SJ</given-names></name><name><surname>McConell</surname><given-names>GK</given-names></name></person-group><article-title>Type 2 diabetic individuals have impaired leg blood flow responses to exercise: role of endothelium-dependent vasodilation</article-title><source>Diabetes Care</source><year>2003</year><volume>26</volume><fpage>899</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.2337/diacare.26.3.899</pub-id><pub-id pub-id-type="pmid">12610056</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>J</given-names></name><name><surname>Watkins</surname><given-names>S</given-names></name><name><surname>Kelley</surname><given-names>DE</given-names></name></person-group><article-title>Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity</article-title><source>Diabetes</source><year>2001</year><volume>50</volume><fpage>817</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.2337/diabetes.50.4.817</pub-id><pub-id pub-id-type="pmid">11289047</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dumas</surname><given-names>JF</given-names></name><name><surname>Simard</surname><given-names>G</given-names></name><name><surname>Flamment</surname><given-names>M</given-names></name><name><surname>Ducluzeau</surname><given-names>PH</given-names></name><name><surname>Ritz</surname><given-names>P</given-names></name></person-group><article-title>Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?</article-title><source>Diabetes Metab</source><year>2009</year><volume>35</volume><fpage>159</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.diabet.2009.02.002</pub-id><pub-id pub-id-type="pmid">19349201</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokota</surname><given-names>T</given-names></name><name><surname>Kinugawa</surname><given-names>S</given-names></name><name><surname>Hirabayashi</surname><given-names>K</given-names></name><name><surname>Matsushima</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>N</given-names></name><name><surname>Ohta</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Oxidative stress in skeletal muscle impairs mitochondrial respiration and limits exercise capacity in type 2 diabetic mice</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2009</year><volume>297</volume><fpage>H1069</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00267.2009</pub-id><pub-id pub-id-type="pmid">19617406</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">Baroni BM, Rodrigues R, Freire BB, Franke Rde A, Geremia JM, Vaz MA. Effect of low-level laser therapy on muscle adaptation to knee extensor eccentric training. Eur J Appl Physiol. 2015, 115:639-647.</mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Miranda EF, de Oliveira LV, Antonialli FC, Vanin AA, de Carvalho Pde T, Leal-Junior EC. Phototherapy with combination of super-pulsed laser and light-emitting diodes is beneficial in improvement of muscular performance (strength and muscular endurance), dyspnea, and fatigue sensation in patients with chronic obstructive pulmonary disease. Lasers Med Sci 2015, 30:437-43. </mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Paolillo FR, Corazza AV, Borghi-Silva A, Parizotto NA, Kurachi C, Bagnato VS. Infrared LED irradiation applied during high-intensity treadmill training improves maximal exercise tolerance in postmenopausal women: a 6-month longitudinal study. Lasers Med Sci. 2013, 28:415-22. </mixed-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraresi</surname><given-names>C</given-names></name><name><surname>de Brito Oliveira</surname><given-names>T</given-names></name><name><surname>de Oliveira Zafalon</surname><given-names>L</given-names></name><name><surname>de Menezes Reiff</surname><given-names>RB</given-names></name><name><surname>Baldissera</surname><given-names>V</given-names></name><name><surname>de Andrade Perez</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Effects of low level laser therapy (808&#x000a0;nm) on physical strength training in humans</article-title><source>Lasers Med Sci</source><year>2011</year><volume>26</volume><fpage>349</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1007/s10103-010-0855-0</pub-id><pub-id pub-id-type="pmid">21086010</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraresi</surname><given-names>C</given-names></name><name><surname>Beltrame</surname><given-names>T</given-names></name><name><surname>Fabrizzi</surname><given-names>F</given-names></name><name><surname>Nascimento</surname><given-names>ES</given-names></name><name><surname>Karsten</surname><given-names>M</given-names></name><name><surname>Francisco</surname><given-names>CO</given-names></name><etal/></person-group><article-title>Muscular pre-conditioning using light-emitting diode therapy (LEDT) for high-intensity exercise: a randomized double-blind placebo-controlled trial with a single elite runner</article-title><source>Physiother Theory Pract</source><year>2015</year><volume>31</volume><fpage>354</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.3109/09593985.2014.1003118</pub-id><pub-id pub-id-type="pmid">25585514</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayworth</surname><given-names>CR</given-names></name><name><surname>Rojas</surname><given-names>JC</given-names></name><name><surname>Padilla</surname><given-names>E</given-names></name><name><surname>Holmes</surname><given-names>GM</given-names></name><name><surname>Sheridan</surname><given-names>EC</given-names></name><name><surname>Gonzalez-Lima</surname><given-names>F</given-names></name></person-group><article-title>In vivo low-level light therapy increases cytochrome oxidase in skeletal muscle</article-title><source>Photochem Photobiol</source><year>2010</year><volume>86</volume><fpage>673</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.2010.00732.x</pub-id><pub-id pub-id-type="pmid">20408982</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraresi</surname><given-names>C</given-names></name><name><surname>Kaippert</surname><given-names>B</given-names></name><name><surname>Avci</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>YY</given-names></name><name><surname>de Sousa</surname><given-names>MV</given-names></name><name><surname>Bagnato</surname><given-names>VS</given-names></name><etal/></person-group><article-title>Low-level Laser (Light) Therapy Increases Mitochondrial Membrane Potential and ATP Synthesis in C2C12 Myotubes with a Peak Response at 3&#x02013;6&#x000a0;h</article-title><source>Photochem Photobiol</source><year>2015</year><volume>91</volume><fpage>411</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/php.12397</pub-id><pub-id pub-id-type="pmid">25443662</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maegawa</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name><name><surname>Hosokawa</surname><given-names>T</given-names></name><name><surname>Yaegashi</surname><given-names>K</given-names></name><name><surname>Nishi</surname><given-names>M</given-names></name></person-group><article-title>Effects of near-infrared low-level laser irradiation on microcirculation</article-title><source>Lasers Surg Med</source><year>2000</year><volume>27</volume><fpage>427</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1002/1096-9101(2000)27:5&#x0003c;427::AID-LSM1004&#x0003e;3.0.CO;2-A</pub-id><pub-id pub-id-type="pmid">11126437</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihsan</surname><given-names>FR</given-names></name></person-group><article-title>Low-level laser therapy accelerates collateral circulation and enhances microcirculation</article-title><source>Photomed Laser Surg</source><year>2005</year><volume>23</volume><fpage>289</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1089/pho.2005.23.289</pub-id><pub-id pub-id-type="pmid">15954817</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Marchi</surname><given-names>T</given-names></name><name><surname>Leal Junior</surname><given-names>EC</given-names></name><name><surname>Bortoli</surname><given-names>C</given-names></name><name><surname>Tomazoni</surname><given-names>SS</given-names></name><name><surname>Lopes-Martins</surname><given-names>RA</given-names></name><name><surname>Salvador</surname><given-names>M</given-names></name></person-group><article-title>Low-level laser therapy (LLLT) in human progressive-intensity running: effects on exercise performance, skeletal muscle status, and oxidative stress</article-title><source>Lasers Med Sci</source><year>2012</year><volume>27</volume><fpage>231</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1007/s10103-011-0955-5</pub-id><pub-id pub-id-type="pmid">21739259</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leal Junior</surname><given-names>EC</given-names></name><name><surname>Lopes-Martins</surname><given-names>RA</given-names></name><name><surname>Frigo</surname><given-names>L</given-names></name><name><surname>De Marchi</surname><given-names>T</given-names></name><name><surname>Rossi</surname><given-names>RP</given-names></name><name><surname>de Godoi</surname><given-names>V</given-names></name><etal/></person-group><article-title>Effects of low-level laser therapy (LLLT) in the development of exercise-induced skeletal muscle fatigue and changes in biochemical markers related to postexercise recovery</article-title><source>J Orthop Sports Phys Ther</source><year>2010</year><volume>40</volume><fpage>524</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.2519/jospt.2010.3294</pub-id><pub-id pub-id-type="pmid">20436237</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leal Junior</surname><given-names>EC</given-names></name><name><surname>Lopes-Martins</surname><given-names>RA</given-names></name><name><surname>Rossi</surname><given-names>RP</given-names></name><name><surname>De Marchi</surname><given-names>T</given-names></name><name><surname>Baroni</surname><given-names>BM</given-names></name><name><surname>de Godoi</surname><given-names>V</given-names></name><etal/></person-group><article-title>Effect of cluster multi-diode light emitting diode therapy (LEDT) on exercise-induced skeletal muscle fatigue and skeletal muscle recovery in humans</article-title><source>Lasers Surg Med</source><year>2009</year><volume>41</volume><fpage>572</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1002/lsm.20810</pub-id><pub-id pub-id-type="pmid">19731300</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leal Junior</surname><given-names>EC</given-names></name><name><surname>Lopes-Martins</surname><given-names>RA</given-names></name><name><surname>Baroni</surname><given-names>BM</given-names></name><name><surname>De Marchi</surname><given-names>T</given-names></name><name><surname>Taufer</surname><given-names>D</given-names></name><name><surname>Manfro</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Effect of 830&#x000a0;nm low-level laser therapy applied before high-intensity exercises on skeletal muscle recovery in athletes</article-title><source>Lasers Med Sci</source><year>2009</year><volume>24</volume><fpage>857</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1007/s10103-008-0633-4</pub-id><pub-id pub-id-type="pmid">19057981</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>TA</given-names></name><name><surname>Reusch</surname><given-names>JE</given-names></name><name><surname>Levi</surname><given-names>M</given-names></name><name><surname>Regensteiner</surname><given-names>JG</given-names></name></person-group><article-title>Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>2880</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.2337/dc07-0843</pub-id><pub-id pub-id-type="pmid">17675540</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>DR</given-names></name><name><surname>Hosker</surname><given-names>JP</given-names></name><name><surname>Rudenski</surname><given-names>AS</given-names></name><name><surname>Naylor</surname><given-names>BA</given-names></name><name><surname>Treacher</surname><given-names>DF</given-names></name><name><surname>Turner</surname><given-names>RC</given-names></name></person-group><article-title>Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man</article-title><source>Diabetologia</source><year>1985</year><volume>28</volume><fpage>412</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/BF00280883</pub-id><pub-id pub-id-type="pmid">3899825</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wasserman</surname><given-names>K</given-names></name><name><surname>Hansen</surname><given-names>JE</given-names></name><name><surname>Sue</surname><given-names>DY</given-names></name><name><surname>Stringer</surname><given-names>WW</given-names></name><name><surname>Whipp</surname><given-names>BJ</given-names></name></person-group><source>Principles of Exercise Testing and Interpretation</source><year>1999</year><edition>3</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Williams &#x00026; Wilkins</publisher-name></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balady</surname><given-names>GJ</given-names></name><name><surname>Arena</surname><given-names>R</given-names></name><name><surname>Sietsema</surname><given-names>K</given-names></name><name><surname>Myers</surname><given-names>J</given-names></name><name><surname>Coke</surname><given-names>L</given-names></name><name><surname>Fletcher</surname><given-names>GF</given-names></name><etal/></person-group><article-title>Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association</article-title><source>Circulation</source><year>2010</year><volume>122</volume><fpage>191</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1161/CIR.0b013e3181e52e69</pub-id><pub-id pub-id-type="pmid">20585013</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>FMS</collab></person-group><source>User's Guide</source><year>2005</year><publisher-loc>Amsterdam</publisher-loc><publisher-name>Finapres Medical Systems BV</publisher-name></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkerson</surname><given-names>DP</given-names></name><name><surname>Poole</surname><given-names>DC</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name><name><surname>Fulford</surname><given-names>J</given-names></name><name><surname>Mawson</surname><given-names>DM</given-names></name><name><surname>Ball</surname><given-names>CI</given-names></name><etal/></person-group><article-title>Older type 2 diabetic males do not exhibit abnormal pulmonary oxygen uptake and muscle oxygen utilization dynamics during submaximal cycling exercise</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2010</year><volume>300</volume><fpage>R685</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00479.2010</pub-id><pub-id pub-id-type="pmid">21178129</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>MD</given-names></name><name><surname>Murias</surname><given-names>JM</given-names></name><name><surname>Kowalchuk</surname><given-names>JM</given-names></name><name><surname>Paterson</surname><given-names>DH</given-names></name></person-group><article-title>Effect of moderate-intensity work rate increment on phase II tauVO(2), functional gain and Delta[HHb]</article-title><source>Eur J Appl Physiol</source><year>2013</year><volume>113</volume><fpage>545</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1007/s00421-012-2460-3</pub-id><pub-id pub-id-type="pmid">22829340</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>MD</given-names></name><name><surname>Murias</surname><given-names>JM</given-names></name><name><surname>Kowalchuk</surname><given-names>JM</given-names></name><name><surname>Paterson</surname><given-names>DH</given-names></name></person-group><article-title>Pulmonary O(2) uptake and muscle deoxygenation kinetics are slowed in the upper compared with lower region of the moderate-intensity exercise domain in older men</article-title><source>Eur J Appl Physiol</source><year>2011</year><volume>111</volume><fpage>2139</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1007/s00421-011-1851-1</pub-id><pub-id pub-id-type="pmid">21298442</pub-id></element-citation></ref></ref-list></back></article>